Protein palmitoylation has emerged as a central post-translational mechanism governing protein localization, stability, and signal transduction. In hematological malignancies, this dynamic modification lies at the intersection of lipid metabolic reprogramming, tumor–immune interactions, and therapeutic resistance. Here...
Qian Zhao, Jian-Gang Mei, Si-Qi Qian et al.· Frontiers in Immunology· 0 citations
G2 is established as a promising therapeutic candidate for surmounting sorafenib resistance, characterized by selective antitumor activity against malignant hepatocellular carcinoma.
Keyan Han, Yuqi Lin, Yu Huang et al.· European journal of medicina...· 0 citations
This review comprehensively highlights the latest advancements in using nanotechnology to enhance cancer immunotherapy and highlights synergistic effects achieved by combining nanoparticles with other treatments like chemotherapy, radiation, photothermal/photodynamic therapy, and more, which can turn hard-to-treat tumo...
U. Cho, Jing-Jing Pu, Amit Sharma et al.· Molecular Cancer· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.